576 related articles for article (PubMed ID: 33410232)
1. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in Alzheimer's disease, vascular dementia and mixed dementia.
Tayler H; Miners JS; Güzel Ö; MacLachlan R; Love S
Brain Pathol; 2021 Jul; 31(4):e12935. PubMed ID: 33410232
[TBL] [Abstract][Full Text] [Related]
2. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia.
Thomas T; Miners S; Love S
Brain; 2015 Apr; 138(Pt 4):1059-69. PubMed ID: 25688080
[TBL] [Abstract][Full Text] [Related]
3. Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.
McAleese KE; Graham S; Dey M; Walker L; Erskine D; Johnson M; Johnston E; Thomas AJ; McKeith IG; DeCarli C; Attems J
Brain Pathol; 2019 May; 29(3):414-424. PubMed ID: 30485582
[TBL] [Abstract][Full Text] [Related]
4. Systemic infection exacerbates cerebrovascular dysfunction in Alzheimer's disease.
Asby D; Boche D; Allan S; Love S; Miners JS
Brain; 2021 Jul; 144(6):1869-1883. PubMed ID: 33723589
[TBL] [Abstract][Full Text] [Related]
5. Pathophysiology of Hypoperfusion of the Precuneus in Early Alzheimer's Disease.
Miners JS; Palmer JC; Love S
Brain Pathol; 2016 Jul; 26(4):533-41. PubMed ID: 26452729
[TBL] [Abstract][Full Text] [Related]
6. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
Barker R; Ashby EL; Wellington D; Barrow VM; Palmer JC; Kehoe PG; Esiri MM; Love S
Brain; 2014 May; 137(Pt 5):1524-32. PubMed ID: 24618270
[TBL] [Abstract][Full Text] [Related]
8. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease.
Miners JS; Schulz I; Love S
J Cereb Blood Flow Metab; 2018 Jan; 38(1):103-115. PubMed ID: 28151041
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
Kurz C; Walker L; Rauchmann BS; Perneczky R
Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
[TBL] [Abstract][Full Text] [Related]
11. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ.
Miners JS; Clarke P; Love S
Brain Pathol; 2017 May; 27(3):305-313. PubMed ID: 27248362
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer's disease-related microvascular cerebral amyloid angiopathy.
Merlini M; Wanner D; Nitsch RM
Acta Neuropathol; 2016 May; 131(5):737-52. PubMed ID: 26988843
[TBL] [Abstract][Full Text] [Related]
13. Elevated late-life blood pressure may maintain brain oxygenation and slow amyloid-β accumulation at the expense of cerebral vascular damage.
Tayler HM; MacLachlan R; Güzel Ö; Miners JS; Love S
Brain Commun; 2023; 5(2):fcad112. PubMed ID: 37113314
[TBL] [Abstract][Full Text] [Related]
14. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
15. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
16. Is later-life depression a risk factor for Alzheimer's disease or a prodromal symptom: a study using post-mortem human brain tissue?
Sinclair LI; Mohr A; Morisaki M; Edmondson M; Chan S; Bone-Connaughton A; Turecki G; Love S
Alzheimers Res Ther; 2023 Sep; 15(1):153. PubMed ID: 37700368
[TBL] [Abstract][Full Text] [Related]
17. Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease.
Shinohara M; Murray ME; Frank RD; Shinohara M; DeTure M; Yamazaki Y; Tachibana M; Atagi Y; Davis MD; Liu CC; Zhao N; Painter MM; Petersen RC; Fryer JD; Crook JE; Dickson DW; Bu G; Kanekiyo T
Acta Neuropathol; 2016 Aug; 132(2):225-234. PubMed ID: 27179972
[TBL] [Abstract][Full Text] [Related]
18. Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.
Barker R; Wellington D; Esiri MM; Love S
J Cereb Blood Flow Metab; 2013 Jul; 33(7):1050-7. PubMed ID: 23532085
[TBL] [Abstract][Full Text] [Related]
19. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
Chalmers K; Wilcock GK; Love S
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):231-8. PubMed ID: 12787320
[TBL] [Abstract][Full Text] [Related]
20. Microbleeds relate to altered amyloid-β metabolism in Alzheimer's disease.
Goos JD; Teunissen CE; Veerhuis R; Verwey NA; Barkhof F; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2012 May; 33(5):1011.e1-9. PubMed ID: 22118945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
